CION Ameerpet
Fertility & Hormones · Reviewed by CION Oncologists · NABH Accredited
Fertility-Sparing Progestin — What the Year Ahead Looks Like
If you are eligible to keep your uterus, the treatment itself is a hormone rather than an operation — and the year that follows has a fairly predictable shape. High-dose progestin, a biopsy every three months to check whether it is working, and an early referral to fertility services once the lining is clear. The treatment is not the demanding part; the surveillance is. Those repeat biopsies are the entire mechanism that makes keeping your uterus a defensible choice rather than a gamble, and a plan without them is not a plan. This page sets out the timeline, honestly, including what happens if it does not work.
- Progestin replaces surgery, temporarily — usually a hormone device, sometimes tablets, sometimes both
- A biopsy roughly every three months — the safety mechanism, and non-negotiable
- Most responses come within six to nine months — with an agreed point at which failure means surgery
- Fertility referral happens early — the window after regression is finite
17+
Cancer Specialists
on Panel
on Panel
35+
Centres
Across India
Across India
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
How the Treatment Works
The logic is the same one that underlies everything about this disease, run in reverse.
Grade 1 endometrioid cancer arises from prolonged oestrogen stimulation and, crucially, usually retains the receptors through which progesterone acts. That means the tumour is still responsive to hormonal signals — and progestin delivers the signal that halts proliferation.
- It causes maturation rather than destruction. Under sustained progestin the abnormal glands stop dividing, mature, and progressively regress. This is why a cancer can be treated with a device fitted in an outpatient clinic.
- A hormone-releasing device is usually central to it. Placed in the cavity, it delivers a very high concentration directly to the lining with far less reaching the rest of the body than tablets would — and it cannot be forgotten. See the hormone IUD.
- Oral progestin is used alongside or instead. Practice varies, and some centres combine both for maximum effect. The choice is clinical rather than a matter of preference.
- Response takes months. Because the mechanism is tissue remodelling rather than cell killing, change is measured in months rather than weeks. That is expected rather than a sign of failure.
For the wider picture of how progestin works and what its side effects are, see progestin therapy.
Did You Know? The endpoint of this treatment is agreed at the beginning, not negotiated later, and that is deliberate. Before starting, you and your team settle on how long treatment will be given before failure to regress means proceeding to hysterectomy — typically six to nine months, with sampling every three. Agreeing it in advance matters because at nine months, feeling entirely well with no symptoms at all, it is extremely difficult to accept surgery you have been avoiding. A woman who agreed the rule when she was frightened and clear-headed is in a far better position than one asked to decide it when she is invested in continuing. Sources: ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma; NCCN Clinical Practice Guidelines in Oncology — Uterine Neoplasms; ESHRE guidance on female fertility preservation.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
The Timeline, Roughly
Individual plans vary between centres, and this is the general shape of a year on this treatment.
| When | What happens |
|---|---|
| Before starting | Eligibility confirmed — expert pathology review, MRI to exclude muscle invasion, often hysteroscopy, and molecular testing. The endpoint is agreed. See who is eligible. |
| Month 0 | Treatment starts. If a hormone-releasing device is being used, it is fitted — often at the same time as a hysteroscopy under anaesthetic, which is convenient and more comfortable. |
| Month 3 | First surveillance sample, usually with hysteroscopy so the cavity is seen as well as sampled. Early irregular bleeding before this point is expected and is not a sign of failure. |
| Month 6 | Second sample. Many women who will respond have done so by now. If the tumour is regressing, treatment continues; if it is unchanged, the conversation about the endpoint begins. |
| Month 9 | Third sample. For most protocols this is around the agreed decision point. Regression confirmed here means moving towards conception; no regression generally means proceeding to surgery. |
| After regression | Referral to reproductive medicine, made promptly. The window before recurrence is finite, so conception is pursued sooner rather than after a long wait. See pregnancy after treatment. |
| Long term | Surveillance continues between and after pregnancies, and hysterectomy is generally recommended once childbearing is complete. See completing treatment. |
The surveillance biopsies are not optional and they are not a formality. They are the only means of knowing whether a cancer left inside your body is regressing or progressing, and they are what makes this approach defensible rather than reckless. A woman who cannot commit to attending them is not a suitable candidate — and that is a statement about the treatment’s requirements, not about her.
Want to Understand What You Would Be Committing To?
The treatment is straightforward. The surveillance is demanding, and it is worth knowing that before you start.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
The Biopsies Are What Make This Safe
A cancer is being left in place deliberately. The surveillance is the reason that is a reasonable thing to do.
The practical detail
What to Expect Along the Way
Women who know the shape of this in advance cope with it considerably better, particularly the parts that feel like setbacks and are not.
Irregular bleeding in the early months
Expected, and the commonest reason women fear the treatment is not working. Unpredictable spotting and light bleeding occur while the lining is being stabilised, and they usually settle. Many women end up with very light bleeding or none. What does warrant reporting is bleeding that is heavy rather than spotting, or bleeding that returns after having settled — that is a different pattern and should be assessed rather than absorbed into the general expectation of irregularity.
The surveillance biopsy itself
Every three months, usually with hysteroscopy so the cavity is seen and sampling is directed rather than blind. Some centres do this under general anaesthetic, others as an outpatient procedure — ask which applies, because it affects planning. If the device is in place it stays in; sampling passes alongside it. The waiting for each result is the hardest part for most women, and it recurs every three months, which is a form of stress worth acknowledging and getting support for.
Side effects of high-dose progestin
Weight gain and increased appetite are the commonest and can be substantial, which matters here because excess weight also worsens the underlying hormonal problem. Fluid retention, bloating and mood change occur. The most clinically important risk is of blood clots — report new calf pain or swelling, breathlessness or chest pain urgently. Where side effects are affecting you, say so rather than stopping: a change of route or dose usually helps and preserves the treatment.
What a "partial response" means
Results are not always a clean yes or no. A sample may show that the carcinoma has gone but hyperplasia remains, or that things have improved without fully clearing. This is common and is generally managed by continuing treatment and resampling rather than by abandoning the approach. It is worth knowing in advance, because a result that is neither the news you hoped for nor the news you feared is disorienting when unprepared for.
The point at which the plan changes
If the tumour has not regressed within the agreed window — typically six to nine months — guidance is to proceed to hysterectomy rather than continue. This is the hardest moment in the whole pathway, because you will feel entirely well and the surgery will feel like a defeat. It is not: it is the plan working as designed, catching a tumour that has not responded while it is still early. This is precisely why the endpoint is agreed at the start.
After a successful pregnancy
Surveillance continues between pregnancies if more than one child is wanted, and hysterectomy is generally recommended once childbearing is complete. This is the part most easily deferred indefinitely, because by then the cancer feels like history and life is full. But the uterus that developed one cancer, in a hormonal environment that has often not changed, remains at risk, and recurrences have been reported years later. See recurrence risk with fertility-sparing treatment.
Want This Route Discussed Properly?
What it involves, what it asks of you, and whether you are eligible — before any surgery is scheduled. The opinion is free.
The Half That Is Not About the Cancer
Clearing the lining is not the goal. A baby is. And a great deal of what determines whether that happens has nothing to do with the progestin.
- Referral to reproductive medicine should be early. Once regression is confirmed, the window before the tumour can return is finite. Waiting to see how things go is the commonest way that window is lost. Assisted reproduction is arranged as a coordinated referral rather than provided in-house.
- Assisted reproduction is frequently involved. Both because it shortens the time to conception and because many women in this situation have the anovulatory background that caused the cancer in the first place and would struggle to conceive naturally. See IVF after endometrial cancer.
- The underlying cause still needs addressing. Weight and insulin resistance drove the tumour, they impair fertility independently, and they raise the chance of recurrence. Addressing them is part of the treatment rather than advice attached to it. See obesity and endometrial cancer.
- The emotional load is substantial. Cancer surveillance and fertility treatment simultaneously, each with its own cycle of waiting and results. Support is a service rather than an indulgence. See emotional health after a diagnosis.
Why This Needs a Team That Will Run It Properly
A cancer is being left in place deliberately. That requires surveillance that actually happens, and fertility care that starts on time.
Fertility taken seriously
Scan and biopsy in one visit
Slides reviewed, not just the summary line
Follow-up you can actually keep
Lynch counselling built in
Psycho-oncology and nutrition on the team
Take The Next Step
Agree the Endpoint Before You Start
It is far easier to accept at month nine if you set it at month zero.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Fertility-Sparing Progestin — Frequently Asked Questions
How does progestin treat an endometrial cancer?
By supplying the hormonal signal the tissue has been missing. Grade 1 endometrioid cancer arises from prolonged oestrogen stimulation and usually retains the progesterone receptors through which that hormone acts, meaning the tumour is still responsive to hormonal signals. High-dose progestin binds those receptors and halts proliferation, causing the abnormal glands to mature and progressively regress rather than killing dividing cells as chemotherapy would. It is usually delivered by a hormone-releasing intrauterine device, which places a very high concentration directly against the lining with much less reaching the rest of the body, sometimes combined with oral progestin. Response develops over months rather than weeks.
How often will I need biopsies, and can I skip any?
Approximately every three months, and no. The surveillance sampling is not a formality — it is the entire mechanism by which leaving a cancer inside your body becomes a defensible choice rather than a gamble, because it is the only way to know whether the tumour is regressing, persisting or progressing. It is usually performed with hysteroscopy so the cavity is seen and sampling is directed rather than blind. The device does not need removing to take a sample. A woman who cannot commit to attending is not considered a suitable candidate, and that is a statement about what the treatment requires rather than a judgement about her.
How long before I can try to become pregnant?
Most women who respond do so within six to nine months, and referral to reproductive medicine is made promptly once regression is confirmed on biopsy rather than after a period of waiting. This urgency is deliberate: the window between clearing the lining and the tumour potentially returning is finite, and delay is the commonest way it is lost. Assisted reproduction is frequently involved, both because it shortens the time to conception and because many women in this situation have the anovulatory background that caused the cancer and would find natural conception difficult. Reproductive medicine is arranged as a coordinated referral.
What happens if the treatment does not work?
If the tumour has not regressed within the agreed window — typically six to nine months, with sampling every three — guidance is to proceed to hysterectomy rather than continue. This endpoint is agreed at the very start of treatment, and that timing is deliberate. At nine months you will feel entirely well with no symptoms, and accepting surgery you have been avoiding is extremely difficult in that state; a rule agreed in advance, when you were clear-headed, is far easier to follow. It is worth understanding that this is not failure but the plan working as designed, catching a non-responding tumour while it is still early and confined.
Do I have to have a hysterectomy afterwards?
It is generally recommended once childbearing is complete, and that expectation should be set out at the beginning rather than raised years later. The reasoning is that the uterus which developed one cancer remains at risk, particularly if the hormonal conditions that caused it — anovulation, excess weight, unopposed oestrogen — have not changed, and recurrences have been reported well after apparently successful treatment. Some women defer it and continue with surveillance instead, which is a decision to make with a specialist and with clear understanding of what is being accepted. What is not reasonable is simply drifting out of follow-up once a baby has arrived.
Medical disclaimer: This page describes fertility-sparing progestin therapy for endometrial cancer in general terms and is reviewed by a CION oncologist, following current NCCN and ESGO–ESTRO–ESP guidance. It describes treatment by hormone class rather than naming individual medicines, and protocols including sampling intervals vary between centres. Eligibility depends on pathology and imaging specific to you. Assisted reproduction is arranged through reproductive medicine services rather than provided in-house. This is not advice about your own treatment.